Predict your next investment

Era7 Bioinformatics company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer


Seed VC | Alive

Total Raised




Last Raised

$630K | 5 yrs ago

About Era7 Bioinformatics

Era7 Bioinformatics is a company involved with Next Generation Sequencing (NGS) services. NGS is a revolution in DNA sequencing impacting a large number of biomedical, biotechnological and industrial activities. Era7's mission is to help its customer obtain the maximum value from their NGS projects.

Era7 Bioinformatics Headquarter Location

1 Broadway 14th Floor

Cambridge, Massachusetts, 02142,

United States


Latest Era7 Bioinformatics News

Era7 Closes €600K Crowdfunded Investment Round

Jan 3, 2017

staff reporter NEW YORK (GenomeWeb) – Spanish bioinformatics firm Era7 announced this week that it has closed a €600,000 ($625,000) crowdfunded investment round. Era7 said the funding will be used to support business development efforts by its US subsidiary based in Cambridge, Massachusetts, and to further integrate and automate the firm’s tools for analyzing microbiomes and bacterial genomes. Get the full story

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Era7 Bioinformatics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Era7 Bioinformatics is included in 1 Expert Collection, including Omics.



1,213 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.